Serum chloride and the response to acetazolamide in patients with acute heart failure and volume overload: a post-hoc analysis from the ADVOR trial
Event:
Heart Failure 2024
Topic:
Pharmacotherapy
Session:
Acute, advanced and worsening heart failure: prognostic aspects
